Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2009-2-27
pubmed:abstractText
In experimental nephropathies, inhibitors of the renin-angiotensin-system (RAS) halted the progression, or even induced a regression in renal injury. We studied the potential of the angiotensin-converting enzyme (ACE) inhibitor perindopril and the angiotensin receptor blocker candesartan to reverse the established renal injury in the obese Zucker rat (OZR).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1421-9670
pubmed:author
pubmed:copyrightInfo
2008 S. Karger AG, Basel.
pubmed:issnType
Electronic
pubmed:volume
29
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
164-70
pubmed:meshHeading
pubmed-meshheading:18753741-Angiotensin II Type 1 Receptor Blockers, pubmed-meshheading:18753741-Angiotensin-Converting Enzyme Inhibitors, pubmed-meshheading:18753741-Animals, pubmed-meshheading:18753741-Benzimidazoles, pubmed-meshheading:18753741-Blood Pressure, pubmed-meshheading:18753741-Body Weight, pubmed-meshheading:18753741-Diabetic Nephropathies, pubmed-meshheading:18753741-Kidney Function Tests, pubmed-meshheading:18753741-Kidney Glomerulus, pubmed-meshheading:18753741-Male, pubmed-meshheading:18753741-Organ Size, pubmed-meshheading:18753741-Oxidative Stress, pubmed-meshheading:18753741-Perindopril, pubmed-meshheading:18753741-Proteinuria, pubmed-meshheading:18753741-Random Allocation, pubmed-meshheading:18753741-Rats, pubmed-meshheading:18753741-Rats, Zucker, pubmed-meshheading:18753741-Tetrazoles
pubmed:year
2009
pubmed:articleTitle
Functional and partial morphological regression of established renal injury in the obese zucker rat by blockade of the renin-angiotensin system.
pubmed:affiliation
Department of Clinical and Experimental Pharmacotherapy, Slovak Medical University, Bratislava, Slovakia. katarina.sebekova@szu.sk
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't